The global telepathology market expected to reach USD 1,462.24 million by 2027, at a CAGR of 10.84% during forecast period 2021-2027. Telepathology referred as practising pathology from a distance and telecommunication technology is used for facilitating the transmission of pathology image rich data between two distant locations for diagnosis, research and education. Pathology plays a very important role in identifying the characteristics and causes of the diseases in medical field. Electronic medical records also increase the administrative efficiency and reduces the medical cost. There are three modes of telepathology are static (or store-and-forward), dynamic (or real-time) and hybrid (or virtual. Static telepathology refers to the process of pre-selection and digitalisation of representative image by sender pathologist and sending it to the remote pathologist via e-mail or internet. Dynamic telepathology is most appropriate system for frozen-selection telepathology and for understaffed area. This involves transmission of microscopic slide images to recipient in real time via live communication. Whereas, hybrid pathology is combining both static and dynamic telepathology modes, a series of images that automatically stitched together in a software, compressed to a single file form and transmitted on the dynamic telepathology session start. Telepathology Market is technology-driven segment of medical field. It is an innovative digital imaging and telecommunication technology that is changing the healthcare delivery systems globally. The regional players are involving in acquisition of the pathology providers that present locally and strengthening their position in market. For instance, in November 2016, Visiopharm A/S acquired LRI Imaging AB, a leading diagnostic digital pathology provider in Sweden to become leader in diagnostic digital pathology. Similarly, in June 2016, Philips acquired an Irish digital pathology firm, PathXL and its digital pathology imaging technology. By this acquisition, Philips seeks to accelerate drive to support global medical institutions and their transition to digitalize workflows.